Company news
Microbot Medical Inc. news in 2022
Microbot Medical Inc.'s news releases, calls and decks from 2022, newest first.
Microbot Medical Announces the Participation of a Key Opinion Leader in the Endovascular Robotics Space at the Next “Access-Ability Live by MBOT” Webinar Series
December 13, 2022
Microbot Medical’s Proprietary LIBERTY® Robotic System Receives Third Patent Allowance in Israel
December 7, 2022
Microbot Medical’s Novel LIBERTY® Robotic System Continues to be Validated with Latest U.S. Design Patent Allowance
November 17, 2022
Microbot Medical Receives Additional Patent Allowance in Israel for the LIBERTY® Robotic System
November 2, 2022
Microbot Medical Adds the Head of the Interventional Radiology Unit of Europe’s Largest Cancer Center, Dr. Thierry Jacques De Baère to its Scientific Advisory Board
October 30, 2022
Microbot Medical Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
October 20, 2022
Microbot Medical Completes GLP Animal Study for the LIBERTY® Robotic System
October 12, 2022
Microbot Medical Enhances Strategic Focus on its Endovascular Solutions
October 10, 2022
Microbot Medical Receives Patent Allowance in Israel for the LIBERTY® Robotic System
October 9, 2022
Microbot Medical Strengthens LIBERTY® Robotic System Portfolio with Acquisition of Novel FDA-Cleared Devices
October 6, 2022
Microbot Medical Announce Strategic Addition to Scientific Advisory Board Appointment
October 3, 2022
Microbot Medical Attracts Another Leading Physician and Expands Capabilities of its Scientific Advisory Board with Addition of Dr. Ripal Gandhi
September 18, 2022
Microbot Medical Enhances its Scientific Advisory Board (SAB) with its Newest Member Dr. Vincent Vidal
September 14, 2022
Microbot Medical Commenced its First Step in the Anticipated Regulatory Process for its LIBERTY® Robotic System
September 11, 2022
Microbot Medical Secures Design Patent Grant in Europe for the LIBERTY® Robotic System
September 5, 2022
Microbot Medical Confirms GLP Pre-Clinical Trial is on Track to Commence Later this Month
September 1, 2022
Microbot Medical Continues to Strengthen Management Team as Rachel Vaknin Promoted to Chief Financial Officer
April 5, 2022
Microbot Medical Achieves Significant Regulatory Milestone for the LIBERTY® Robotic System; Files FDA Pre-Submission Package for Regulatory Pathway
March 30, 2022
Decks in 2022
- Investor Presentation (April 2022)
Investor deck · 11 slides · Apr 12, 2022
- Investor Presentation (January 2022)
Investor deck · 11 slides · Jan 10, 2022